Michael S. Anderson, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 3,000 shares at $6.44 ($19K) on 2018-05-24, disclosed to the SEC on 2018-05-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AVDL | BUY | 2017-12-11 | $44K | — | Filing → |
| AVDL | BUY | 2017-09-14 | $39K | — | Filing → |
| AVDL | BUY | 2017-05-22 | $25K | — | Filing → |